For those managing diabetes, the medication Jardiance is a common choice. However, many patients often inquire, what is the generic for Jardiance? Understanding its generic counterpart can help in making informed decisions about treatment options.
What is Jardiance?
Jardiance, also known by its chemical name empagliflozin, is an oral medication used to improve blood sugar control in adults with type 2 diabetes. It belongs to a class of drugs called SGLT2 inhibitors, which work by preventing the reabsorption of glucose in the kidneys, leading to lower blood sugar levels.
The Generic Equivalent
The generic name for Jardiance is empagliflozin. This means that when looking for a more affordable option or considering insurance coverage, patients can ask their healthcare provider about empagliflozin as a potential substitute. The effectiveness and safety profile remain similar between the brand and its generic version, making it a suitable alternative for many.
Benefits of Choosing the Generic
Choosing a generic medication like empagliflozin can offer several advantages:
- Cost-Effective: Generics are typically less expensive than their brand-name counterparts.
- Same Efficacy: The FDA requires generics to meet strict standards, ensuring they perform similarly to the brand-name drug.
- Availability: With the increasing number of generic drugs on the market, availability has improved, allowing for easier access.
Consulting Your Healthcare Professional
Before making any changes to your diabetes management plan, it’s crucial to consult with your healthcare provider. They can provide recommendations based on your specific health needs and ensure that switching to empagliflozin is appropriate what is the generic for jardiance for you.
For more information on diabetes medications and their generics, visit Drugs.com.
Conclusion
In summary, understanding what is the generic for Jardiance helps patients become active participants in their health care. By opting for empagliflozin, patients can maintain effective diabetes management while potentially reducing their medication costs.